Document:

Exhibit 10.2

 

AMENDMENT 

 

TO
A BINDING TERM SHEET BETWEEN LEO RODERS COMPANY AND BIO EN HOLDINGS CORP

 

BACKGROUND

 

	1.	LEO and BIO entered into a Binding Term Sheet dated 26th November 2019, (the “Term
Sheet” or "TS").

 

	2.	LEO and BIO now wish to make certain amendments to the Term Sheet.

 

	3.	This Amendment amends the Term Sheet and, subject to the amendments described in this Amendment,
and compliance with the obligation and conditions set forth in the Terms Sheet, it shall remain in full force and effect.

 

	4.	Amendments to the Term Sheet

 

It is agreed that the Term Sheet shall be amended as set forth
below:

 

	5.	It is agreed that Bio with Leo shall raise up to $2 million (the “Investment”)
within 120 days (and not 6 has was written at the TS).

 

	6.	The following paragraph on page 5 of the TS shall be deleted:

 

"After signing the final agreement
and before raising the funds from the investors, Bio will transfer to LEO 400,000$ as a loan ( until the final agreement is signed
between $ 100,000 200,000 US dollar to LEO) which will be paid back by Leo upon raising the funds, All details for this will be
at section 4 of the contract "

 

Conditions "

 

If Leo would like to exit this contract
from any reason, Leo will transfer 50% of the company shares to BIO as a penalty.

 

If Bio will not raise the money for
Leo, the 400k which has been given to Leo as a loan will be transferred to 5% of Leo at 9M valuation".

 

And Shall be replaced with the following
paragraph:

 

" Bio shall transfer to LEO
a sum of $460,000 as a loan (the “Loan”) according to the following dates :

 

$120,000 has been already transferred
prior to signature of this Amendment (through a wire of 85,000$ by BIO and additional wire of 35,000$ by Sourcing).

 

     

     

    

 

$340,000 shall be transferred by BIO
according to the following list of payments and subject to the following preconditions:

 

		A:	BIO and LEO shall agree within 2 days on LEO's cash flow program, including list of payments
and payment schedule that the company is entitled to pay to third parties (including debt to suppliers, employees, bank and authorities).
Following the signature of such cash flow by both parties, this cash flow shall be attached to this Amendment as appendix A ("the
cash flow”).

 

		B :	Bank Apoalim shall confirm in writing a re- finance of the loans of LEO to Bank Apoalim according
to the following :

 

120,000 NIS – immediate
payment ( this sum shall be transferred to LEO on 14/11/19 by Mr Kfir Ben Shoshan as a Loan) 

 

380,000 NIS BY 31/12/19 (to
be paid by LEO out from the above Loan of 340,000$ )

 

The balance shall be paid by
LEO from 1/1/2020 to 31/12/2020 by 12 monthly installments 

 

The Bank shall grant a credit
of 100,000 NIS to LEO 

 

Conditions:

 

If Leo would like to exit this contract
from any reason ( other than in the event of a breach of the agreement by Bio) of if LEO shall breach its commitments under the
TS and/or this amendment, Leo will transfer 50% of the company shares to BIO ( with no consideration) as a penalty without derogating
of any other remedy of BIO .

 

If Bio will not raise the Investment
for Leo, the portion of the Loan which has been received by Leo shall be either (i) converted to ordinary shares ( or preferred
shares if such shares exits) of Leo at a post money valuation of $5M, or (ii) repaid be Leo no later than 90 days thereafter, this
according to the sole discretion of BIO. ".

 

	7.	All payments by LEO to third parties that are not part of the agreed cash flow shall be subject
to BIO's prior written consent. In case LEO shall use the above funds (without BIO's prior approval) for purposes that are different
of those agreed under the cash flow, of if LEO shall breach its commitments under the TS and/or this amendment, Leo will transfer
50% of the company shares to BIO ( with no consideration) as a penalty without derogating of any other remedy of BIO ,and the current
management of the company shall personally compensate BIO for such breach.

 

	8.	The Debt to Teddy Sagi and to C.T connection shall not be repaid by LEO , from the funds transferred
to LEO by BIO.

 

	9.	The Salary of Mr Eldad Berkowitz as LEO CEO, for 10-12/2019 and 1/2020, shall be 30,000 NIS including
VAT against an invoice. By 2/2020 an employment agreement shall be signed with Eldad.

 

	10.	The debt of LEO to its current shareholders (including to Inokim) and to Eldad (salary debt up
to 10/2019) shall be converted to shares of LEO before the merger.

 

	11.	The monthly payment to Aviv Technology shall not exceed 35000 NIS.

 

     

     

    

 

	12.	All payment to other suppliers (that are not part of the agreed cash flow) shall be postponed at
least to 3/2020 at payments schedule that shall be agreed by the parties.

 

	13.	Funds that the LEO shall raise and/or receive beyond the above Loan shall be served to pay
debt to third parties according to the cashflow, as shall be agreed by the parties.

 

	14.	The parties shall cooperate in order to fulfill the merger of BIO and LEO as agreed under the TS
and this amendment. Until the Merger, all decisions and/or actions and/or engagements of LEO beyond the normal course of action,
shall be subject to BIO's prior written consent. LEO shall send BIO a weekly report regarding financial status and shall forward
BIO all details and information regarding the company, that BIO shall request.

 

	15.	In case Bio shall not transfer the payment of 340,000$ according to its commitment under this Amendment,
LEO shall have the right to convert the above Loan of 460,000$ to ordinary shares of Leo at a post money valuation of $5M or to
refund BIO's loan within 90 days.

 

	16.	Until the date of the Merger, LEO shall be entitled to raise funds from investors and/or third
parties. However, any such engagement shall be subject to the prior consent of BIO.

 

	17.	For the avoidance of doubt, BIO's Loan shall have priority with regard to any other Loan and/or
debt of LEO to its shareholders.

 

 

 

In witness whereof, we have duly affixed
our signatures on 26 November 2019:

  

 

	/s/ Dror Benshooshan	 	/s/ Barry Adika
	LEO RIDERS COMPANY 	 	BIO  EN  HOLDINGS CORPEXECUTIVE
AGREEMENT

 

FOR

 

CIPHERLOC
CORPORATION

 

This
Agreement (the “Agreement”) is entered into November 25, 2019, by and between CIPHERLOC CORPORATION (“the Company”)
and Andrew Borene (“Executive”). Executive is an at-will employee of the Company. The provisions of the Offer Letter
are incorporated by reference into this document. Additionally, the Company wishes to provide Executive with severance benefits
if Executive’s employment is terminated in connection with a change in control.

 

NOW,
THEREFORE, in consideration of the foregoing recitals and the covenants and conditions contained herein, the parties hereby agree
as follows:

 

1.
Severance.

 

(a)
If the Company terminates Executive’s employment (other than for Cause) or Executive resigns for Good Reason, the Company
shall pay to Executive the Severance Payment immediately from an escrow account held by the Company’s counsel, Sheppard
& Mullin. For purposes of this Agreement, termination from employment shall mean a “separation from service” as
defined under the default rules under the final Section 409A regulations.

 

(b)
The Severance Payment shall be equal to one year of salary at the then current annual rate, or $350,000, whichever is
greater.

 

(c)
For the first three years of service, not less than $350,000 shall be set aside and held in escrow by the Company’s external
counsel, Sheppard & Mullin.

 

(d)
Each of the following shall constitute “Good Reason”, and provided further that Executive must provide notice to the
Company within sixty (60) days of the existence of such condition and the Company will have thirty (30) days from receipt of such
notice to remedy the condition. If the condition is not remedied within such 30 day period, the following conditions will constitute
“Good Reason”:

 

(1)
the material diminution of Executive’s position, duties, responsibilities or status with the Company or its successor, as
compared with the position, duties, responsibilities or status of Executive with the Company immediately prior to the Event Date,
except in connection with the termination of Executive for Cause;

 

(2)
the Company’s assignment of Executive on a substantially full-time basis to work at a location where the distance between
the new location and Executive’s principal residence is at least 35 miles greater than the distance between the former location
and such residence; provided, however, that this paragraph shall not apply to travel in the furtherance of the Company’s
business to an extent substantially consistent with Executive’s business travel obligations as of the date hereof;

 

(3)
the Company’s failure to obtain an assumption of the obligations of the Company to perform this Agreement by any successor
to the Company;

 

    	 	1	 

     

    

 

(4)
any material reduction in Executive’s base salary, or a material reduction in benefits payable to Executive or failure of
the Company to pay Executive any earned salary, bonus or benefits except with the prior written consent of Executive;

 

(5)
the exclusion or limitation of Executive from participating in some form of variable compensation plan which provides the Executive
the opportunity to achieve a level of total compensation (base salary plus variable compensation) consistent with what the Executive
had the opportunity to earn at the Event Date; or

 

(6)
any demand by any director or officer of the Company that Executive take any action or refrain from taking any action where such
action or inaction, as the case may be, would violate any law, rule, regulation or other governmental pronouncement, court order,
decree or judgment, or breach any agreement or fiduciary duty.

 

(e)
Each of the following shall constitute “Cause”:

 

(1)
any violation by Executive of any material obligation under this Agreement or the attached Confidentiality and Non-Disclosure
Agreement;

 

(2)
any action or failure to act by Executive which causes the Company to incur significant monetary damages;

 

(3)
conviction for commission of a felony;

 

(4)
any violation of law by the Executive, which has a material, adverse effect on the Company;

 

(5)
habitual abuse of alcohol or a controlled substance;

 

(6)
theft or embezzlement from the Company;

 

(7)
repeated unexcused absence from work for reasons unrelated to short-term illnesses;

 

(8)
the failure by Executive substantially to achieve personal performance goals reasonably established by the board of directors
other than where such failure is substantially attributable to factors beyond control of Executive;

 

(9)
Disability of Executive (as defined below); and

 

(10)
repeated failure or refusal by Executive to carry out the reasonable directives, orders or resolutions of the Company’s
Board of Directors or any officer to whom he/she reports.

 

(f)
“Disability” shall mean any physical, mental or other health condition which substantially impairs
Executive’s ability to perform his/her assigned duties for 90 days or more in any 180 day period or that can be
expected to result in death. Any disagreement as to whether Executive is disabled shall be resolved by a physician selected
by the Company after an examination of Executive. Executive hereby consents to such physical examination and to the
examination of all medical records of Executive necessary, in the judgment of the examining physician, to make the
determination of disability.

 

    	 	2	 

     

    

 

2.
Company Sale or Liquidation Bonus. If, during the term of service, the Company or substantially all the assets of the Company
are sold in a transaction approved by a majority of the shareholders, the Executive will receive a bonus of not less than 2.5%
of the Net Proceeds. Net Proceeds shall be defined as the stated purchase price, less costs incurred to complete the sale, to
include but not limited to accounting, legal, due diligence, commissions, investment banking fees or similar costs that are necessitated
by the sale. The date for determination of such amount shall be as of the effective date of the sale, merger, consolidation or
change in control and the bonus shall be paid by within thirty (30) days after that effective date.

 

3.
Confidentiality and Non-Competition Agreement. In consideration of the obligations undertaken by the Company pursuant to
this Agreement, contemporaneously with the execution of this Agreement, Executive and the Company have entered into the form of
Confidentiality and Non-Competition Agreement attached hereto as Exhibit A and each agreement shall be effective only if
both agreements have been executed.

 

4.
At Will Employment. Unless and to the extent otherwise agreed by the Company and Executive in a separate written employment
agreement, Executive’s employment shall be “at will”, with either party permitted to terminate the employment
at any time, with or without cause. No term of any employment agreement between the Company and Executive shall be construed to
conflict with, lessen or expand the obligations of the parties under this Agreement.

 

5.
Notices. All notices and other communications called for or required by this Agreement shall be in writing and shall be
addressed to the parties at their respective addresses stated below or to such other address as a party may subsequently specify
by written notice and shall be deemed to have been received (i) upon delivery in person, (ii) five days after mailing it by U.S.
certified or registered mail, return receipt requested and postage prepaid, or (iii) two days after depositing it with a commercial
overnight carrier which provides written verification of delivery:

 

To
the Company:

 

Attention:
Chairman of the Board of Directors

Cipherloc
Corporation

825
S. Main Street, Suite 100

Buda,
Texas 78610

 

	 	To
    Executive:	SUPPLIED
    TO COMPANY

 

6.Withholding.
All payments due to and all benefits to be provided to Executive hereunder shall be subject to reduction for any applicable withholding
taxes, including excise taxes.

 

7.
Assignment. Executive’s rights and duties hereunder are personal to Executive and are not assignable to others, but
Executive’s obligations hereunder will bind his/her heirs, successors, and assigns. The Company may assign its rights under
this Agreement in connection with any merger or consolidation of the Company or any sale of all or any portion of the Company’s
assets (including, without limitation, any division or product line), provided that any such successor or assignee expressly assumes
in writing the Company’s obligations hereunder.

 

    	 	3	 

     

    

 

8.
No Duty to Mitigate. Executive shall not be required to mitigate the amount of any payment made or benefit provided hereunder.
The Company may offset any payment due hereunder by the amount of damages to the Company resulting from any breach of this Agreement
by Executive.

 

9.
Indemnification for Prior Acts and Events. It is expressly understood and agreed by the parties hereto that the Executive
shall not be liable for any act or matters arising out of any act committed by Company officers prior to the Executive’s
tenure at the Company. Executive will also not be liable for any act or omission that occurred at the Company prior to his employment.
Executive will therefore be indemnified and held harmless for any act or omission before his first full day of employment with
the Company.

 

9.
General. This Agreement constitutes the exclusive agreement of the parties with respect to the subject matter hereof and
supersedes all prior agreements or understandings of the parties. No waiver of or forbearance to enforce any right or provision
hereof shall be binding unless in writing and signed by the party to be bound, and no such waiver or forbearance in any instance
shall apply to any other instance or to any other right or provision. This Agreement will be governed by the local laws of the
State of Texas without regard to its conflicts of laws rules to the contrary. The parties hereby consent to the exclusive jurisdiction
and venue of the state and federal courts sitting in Travis County, Texas for all matters and actions arising under this Agreement.
The prevailing party shall be entitled to reasonable attorneys’ fees and costs incurred in connection with such litigation.
No term hereof shall be construed to limit or supersede any other right or remedy of the Company under applicable law with respect
to the protection of trade secrets or otherwise. If any provision of this Agreement is held to be invalid or unenforceable to
any extent in any context, it shall nevertheless be enforced to the fullest extent allowed by law in that and other contexts,
and the validity and force of the remainder of this Agreement shall not be affected thereby.

 

    	 	4	 

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the date first above written.

 

	CIPHERLOC CORPORATION	 	EXECUTIVE:
	 	 	 	 	 
	By:	/s/
    Tom Wilkinson	 	By:	/s/
    Andrew Borene
	Name:	Tom
    Wilkinson	 	Name:	Andrew
    Borene

 

    	 	5	 

     

    

 

Exhibit
A

 

CONFIDENTIALITY
AND NON-COMPETITION AGREEMENT

 

FOR

 

CIPHERLOC
CORPORATION

 

This
Agreement is entered into effective this 25th day of November, 2019, by and between CIPHERLOC CORPORATION (“the
Company”) and Andrew Borene (“Executive”). Executive is an at-will employee of the Company. In consideration
of entering into an agreement to provide Executive with severance benefits if Executive’s employment is terminated in connection
with a change in control in the Company, Executive promises, on the terms set forth herein, at all times to protect the Company’s
proprietary information and to not compete with the Company following termination of Executive’s employment in connection
with a change in control.

 

NOW,
THEREFORE, in consideration of the foregoing recitals and the covenants and conditions contained herein, the parties hereby agree
as follows:

 

1.
Intellectual Properties.

 

(a)
All ownership, copyright, patent, trade secrecy, and other rights in all works, programs, software, fixes, routines, inventions,
ideas, designs, manuals, improvements, discoveries, processes, customer lists or other properties (the “Intellectual Properties”)
made or conceived by Executive during the term of his/her employment by the Company shall be the rights and property solely of
the Company, whether developed independently by Executive or jointly with others, and whether or not developed or conceived during
regular working hours or at the Company’s facilities, and whether or not the Company uses, registers, or markets the same.

 

(b)
In accordance with the Company’s policy and Texas law, this Agreement (other than Subsection 1(c)) does not apply to, and
Executive has no obligation to assign to the Company, any invention for which no Company trade secrets and no equipment, supplies,
or facilities of the Company were used and which was developed entirely on Executive’s own time, unless: (i) the invention
relates directly to the business of the Company, (ii) the invention relates to actual or demonstrably anticipated research or
development work of the Company, or (iii) the invention results from any work performed by Executive for the Company.

 

(c)
If and to the extent that Executive makes use, in the course of his/her employment, of any items or Intellectual Properties previously
developed by Executive or developed by Executive outside of the scope of this Agreement, Executive hereby grants the Company a
nonexclusive, royalty-free, perpetual, irrevocable, worldwide license (with right to sublicense) to make, use, sell, copy, distribute,
modify, and otherwise to practice and exploit any and all such items and Intellectual Properties.

 

(d)
Executive will assist the Company as reasonably requested during and after the term of his/her employment to further evidence
and perfect, and to enforce, the Company’s rights in and ownership of the Intellectual Properties covered hereby, including
without limitation, the execution of additional instruments of conveyance and assisting the Company with applications for patents
or copyright or other registrations.

 

2.
Trade Secrets and Confidential Information.

 

(a)
Executive acknowledges that the Company’s business and future success depends on the preservation of the trade secrets and
other confidential information of the Company and its suppliers and customers (the “Secrets”). The Secrets may include,
without limitation, existing and to-be-developed or acquired product designs, new product plans or ideas, market surveys, the
identities of past, present or potential customers, business and financial information, pricing methods or data, terms of contracts
with present or past customers, proposals or bids, marketing plans, personnel information, procedural and technical manuals and
practices, servicing routines, and parts and supplier lists proprietary to the Company or its customers or suppliers, and any
other sorts of items or information of the Company or its customers or suppliers which are not generally known to the public at
large. Executive agrees to protect and to preserve as confidential during and after the term of his/her employment all of the
Secrets at any time known to Executive or in his/her possession or control (whether wholly or partially developed by Executive
or provided to Executive, and whether embodied in a tangible medium or merely remembered).

 

    	 	6	 

     

    

 

(b)
Executive shall mark all items containing any of the Secrets with prominent confidentiality notices acceptable to the Company.
Executive shall neither use nor allow any other person to use any of the Secrets in any way, except for the benefit of the Company
and as directed by Executive’s supervisor. All material containing or disclosing any portion of the Secrets shall be and
remain the property of the Company, shall not be removed from the Company’s premises without specific consent from an officer
of the Company, and shall be returned to the Company upon the termination of Executive’s employment or the earlier request
Executive’s supervisor. At such time, Executive shall also assemble all materials in his possession or control which contain
any of the Secrets, and promptly deliver such items to the Company.

 

3.
Authority and Non-Infringement. Executive warrants that any and all items, technology, and Intellectual Properties of any
nature developed or provided by Executive under this Agreement and in any way for or related to the Company will be original to
Executive and will not, as provided to the Company or when used and exploited by the Company and its contractors and customers
and its and their successors and assigns, infringe in any respect on the rights or property of Executive or any third party. Executive
will not, without the prior written approval of the Company, use any equipment, supplies, facilities, or proprietary information
of any other party. Executive warrants that Executive is fully authorized to enter into employment with the Company and to perform
under this Agreement, without conflicting with any of Executive’s other commitments, agreements, understandings or duties,
whether to prior employers or otherwise. Executive will indemnify the Company for all losses, claims, and expenses (including
reasonable attorneys’ fees) arising from any breach of by him/her of this Agreement.

 

4.
Non-competition and Non-solicitation.

 

(a)
Executive agrees that during the term of his/her employment with the Company and, if Executive receives the Severance Payment
(as defined below), until the first anniversary of the Termination Date (as defined below), he/she will not in any capacity
directly or indirectly engage in, assist others to engage in or own a material interest in any business or activity that is,
or is preparing to be, in competition with the Company with respect to any product or service sold or service provided by the
Company up to the time of termination of employment in any geographical area in which at the time of termination of
employment such product or service is sold or actively is engaged in. For the purposes of this Agreement, the terms
“Severance Payment” and “Termination Date” shall have the meanings assigned to them in the Executive
Agreement (as defined in Section 6 below).

 

(b)
Executive further agrees that during the period stated above, he/she will not directly or indirectly call on, reveal the name
of, or otherwise solicit, accept business from or attempt to entice away from the Company any actual or identified potential
customer of the Company, nor will he/she assist others in doing so. Executive further agrees that he/she will not, during the
period stated above, encourage or solicit any other employee or consultant of the Company to leave such employment for any
reason, nor will he/she assist others to do so.

 

(c)
Executive acknowledges that the covenants in this section are necessary and reasonable to protect the Company in the conduct
of its business and that compliance with such covenants will not prevent him/her from pursuing his/her livelihood. However,
should any court find that any provision of such covenants is unreasonable, invalid or unenforceable, whether in period of
time, geographical area, or otherwise, then in that event the parties hereby agree that such covenants shall be interpreted
and enforced to the maximum extent which the court deems reasonable.

 

5.
Remedies. The harm to the Company from any breach of Executive’s obligations under this Agreement may be difficult
to determine and may be wholly or partially irreparable, and Executive agrees that such obligations may be enforced by injunctive
relief and other appropriate remedies, as well as by damages. If any bond from the Company is required in connection with such
enforcement, the parties agree that a reasonable value of such bond shall be $5,000. Any amounts received by Executive or by any
other through Executive in breach of this Agreement shall be held in constructive trust for the benefit of the Company.

 

6. Executive
Agreement. In consideration of the obligations undertaken by Executive pursuant to this Agreement, contemporaneously
with the execution of this Agreement, Executive and the Company shall enter into the form of Executive Agreement to which
this Agreement is attached (the “Executive Agreement”), and each agreement shall be effective only if both
agreements have been executed.

 

    	 	7	 

     

    

 

7.
At Will Employment. Unless and to the extent otherwise agreed by the Company and Executive in a separate written employment
agreement, Executive’s employment shall be “at will”, with either party permitted to terminate the employment
at any time, with or without cause. No term of any employment agreement between the Company and Executive shall be construed to
conflict with or lessen Executive’s obligations under this Agreement.

 

8. Notices.
All notices and other communications called for or required by this Agreement shall be in writing and shall be addressed to
the parties at their respective addresses stated below or to such other address as a party may subsequently specify by
written notice and shall be deemed to have been received (i) upon delivery in person, (ii) five days after mailing it by U.S.
certified or registered mail, return receipt requested and postage prepaid, or (iii) two days after depositing it with a
commercial overnight carrier which provides written verification of delivery:

 

To
the Company:

 

Attention:
Chairman of the Board of Directors

Cipherloc
Corporation

825
S. Main Street, Suite 100

Buda,
Texas 78610

 

	 	To
    Executive:	SUPPLIED
    TO COMPANY

 

9. Assignment.
Executive’s rights and duties hereunder are personal to Executive and are not assignable to others, but
Executive’s obligations hereunder will bind his/her heirs, successors, and assigns. The Company may assign its rights
under this Agreement in connection with any merger or consolidation of the Company or any sale of all or any portion of the
Company’s assets (including, without limitation, any division or product line), provided that any such successor or
assignee expressly assumes in writing the Company’s obligations under the Executive Agreement.

 

10.
General. This Agreement constitutes the exclusive agreement of the parties with respect to the subject matter hereof and
supersedes all prior agreements or understandings of the parties. No waiver of or forbearance to enforce any right or provision
hereof shall be binding unless in writing and signed by the party to be bound, and no such waiver or forbearance in any instance
shall apply to any other instance or to any other right or provision. This Agreement will be governed by the local laws of the
State of Texas without regard to its conflicts of laws rules to the contrary. The parties hereby consent to the exclusive jurisdiction
and venue of the state and federal courts sitting in Travis County, Texas for all matters and actions arising under this Agreement.
The prevailing party shall be entitled to reasonable attorneys’ fees and costs incurred in connection with such litigation.
No term hereof shall be construed to limit or supersede any other right or remedy of the Company under applicable law with respect
to the protection of trade secrets or otherwise. If any provision of this Agreement is held to be invalid or unenforceable to
any extent in any context, it shall nevertheless be enforced to the fullest extent allowed by law in that and other contexts,
and the validity and force of the remainder of this Agreement shall not be affected thereby.

 

    	 	8	 

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the date first above written.

 

	CIPHERLOC CORPORATION	 	EXECUTIVE:
	 	 	 	 	 
	By: 	/s/
    Tom Wilkinson	 	By: 	/s/
    Andrew Borene
	Name: 	Tom Wilkinson	 	Name:	Andrew Borene

 

    	 	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]